Clinical Trial Update: Combine TACE and Autologous Tcm Immunotherapy Versus TACE Alone for HCC With MVI After Radical Resection [Phase 2]

View source ↗

Summary

Phase 2 trial comparing combined transarterial chemoembolization (TACE) with autologous Tcm immunotherapy versus TACE alone in hepatocellular carcinoma with mic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TACE
• autologous Tcm immunotherapy

Snippet

Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Conditions: Hepatocellular Carcinoma, Malignant Neoplasm | Phase 2 | Status: COMPLETED | Results posted: 2020-05-21